2.12 USD
+0.04 (+1.92%)
2.12 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to CCCC. The Buy consensus is the weighted average rating of the current analysts ratings.
CCCC was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CCCC.
In the previous month the buy percentage consensus was at a similar level.
CCCC was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-02 | TD Cowen | Initiate | Buy |
| 2025-09-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-22 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-09-17 | Barclays | Initiate | Overweight |
| 2025-09-15 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2025-09-04 | Guggenheim | Initiate | Buy |
| 2024-12-19 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-11-18 | Stephens & Co. | Initiate | Equal-Weight |
| 2024-08-06 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-05-09 | Stifel | Maintains | Buy -> Buy |
| 2024-05-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-23 | Stifel | Reiterate | Buy -> Buy |
| 2024-01-29 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023-12-13 | Stifel | Upgrade | Hold -> Buy |
| 2023-11-06 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-11-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-09 | B of A Securities | Maintains | Neutral -> Neutral |
| 2023-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-30 | Evercore ISI Group | Maintains | Outperform |
| 2023-05-12 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-05-08 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-28 | B of A Securities | Maintains | Neutral |
| 2023-02-27 | Morgan Stanley | Maintains | Underweight |
| 2023-02-24 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | Wells Fargo | Maintains | Equal-Weight |
C4 THERAPEUTICS INC / CCCC FAQ
What is the consensus rating for CCCC stock?
The consensus rating for C4 THERAPEUTICS INC (CCCC) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for C4 THERAPEUTICS INC stock?
The number of analysts covering C4 THERAPEUTICS INC (CCCC) is 13.